Corbus Pharmaceuticals Holding (CRBP)

2.0700
+0.0800(+4.02%)
After Hours
2.0100
-0.0600(-2.8986%)
- Real-time Data
  • Volume:
    21,584,882
  • Bid/Ask:
    2.0000/2.0100
  • Day's Range:
    1.6100 - 2.0900

CRBP Overview

Prev. Close
1.99
Day's Range
1.61-2.09
Revenue
2.83M
Open
1.68
52 wk Range
0.91-9.76
EPS
-1.18
Volume
21,584,882
Market Cap
248.82M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,226,844
P/E Ratio
-
Beta
1.77
1-Year Change
-73.99%
Shares Outstanding
125,033,006
Next Earnings Date
Aug 11, 2021
What is your sentiment on Corbus Pharmaceuticals Holding?
or
Market is currently closed. Voting is open during market hours.

Corbus Pharmaceuticals Holding News

Corbus Pharmaceuticals Holding Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyBuyStrong Sell

Corbus Pharmaceuticals Holding Company Profile

Corbus Pharmaceuticals Holding Company Profile

Employees
76

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. Its lead product candidate is lenabasum, a cannabinoid receptor type 2 (CB2) that is in Phase III clinical trial for the treatment of dermatomyositis; and in Phase II clinical trial to treat systemic lupus erythematosus. The company is also developing cannabinoid receptor type 1 inverse agonist program for treatment of metabolic disorders, such as obesity, diabetic nephropathy, diabetic retinopathy, and nonalcoholic steatohepatitis; and CB2 agonist program for the treatment of cancer. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, which includes the Jenrin library of approximately 600 compounds and multiple issued and pending patent filings; and strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was incorporated in 2009 and is based in Norwood, Massachusetts.

Read More
  • Fly take your place 🕺🏼
    0
    • This company cant do anything
      2
      • when is it prepare to visit moon because am tired in waiting for being a bagholder 😑😑😑
        0
        • yo te moon
          1
          • this is very good stock. 2022 - 6 dollar. to the moon.
            1
            • HOLD future is bright!
              0
              • just hold this stock target 3 $ soon
                0
                • Corbus recently started a 16-week study on the effectiveness of Lenabasum on Lupus. It will be the end of the year, before the data, from the study, will be published.
                  0
                  • 5-6 soon 🚀🚀🚀
                    0
                    • what's the logic behind big upside target...? I have buy at 2.70
                      0
                  • Check Innocan Pharma Stock - soon reach $1
                    5
                    • Corbus needs the pandemic to end. Then, and only then, can the re-start their studies.
                      0
                      • this is very good. go to the 5$
                        1
                        • hit 3 $ first, 5$ need a long time
                          0
                      • crbp 💎💎💎🤩🍗 buy it before to late
                        1
                        • 2.7 soon 🤑🤑
                          0
                          • Is it Hope ? or intuition ?
                            0
                          • a gap chart 2.75 to 2.6 it must to close i think
                            0
                        • Come on reddit where are you
                          0
                          • game over..
                            3
                            • I bought at 3... should I hold or exit...?
                              0
                            • I bought at 3... should I hold or exit...?
                              0
                            • Veerdev Chahal sell %50...you can buy EVFM or anything else. Hold with %50
                              1
                          • what is happening since 19:40?
                            0
                            • Going in the right direction! Im all in!!
                              0
                              • Reddit are coming for CRBP
                                0
                                • 5-6 soon
                                  0
                                  • Add more at this price what a gift!
                                    0
                                    • New Jersey has signed a mj bill that should help this stock
                                      2
                                      • what you mean Bro ?
                                        0
                                      • This stock seems to be connected to the *******stocks...
                                        0
                                    • stock is for sale! Im buying more
                                      0
                                      • More of it
                                        0
                                        • 5 soon
                                          0
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.